COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,946 Articles (22,604 medRxiv, 8,342 bioRxiv)

Most recent first Previous |  Page 2164: Articles 21631-21640  | Next

Willingness of Nigerian residents to disclose COVID-19 symptoms and take COVID-19 test
Oladoyin, V. O., Okunlola, O. A., Israel, O. K., Ibirongbe, D. O., Osifo, J. A., Obembe, T. A., Omode, P. K., Osunmakinwa, O. O.
10.1101/2020.10.02.20205914 — Posted: 2020-10-05
Extremely preterm infant admissions within the SafeBoosC-III consortium during the COVID-19 lockdown
Rasmussen, M. I., Hansen, M. L., Pichler, G., Dempsey, E., Pellicer, A., EL-Khuffash, A., A, S., Piris-Borregas, S., Alsina, M., Cetinkaya, M., Chalak, L., Ozkan, H., Baserga, M., Sirc, J., Fuchs, H., Ergenekon, E., Arruza, L., Mathur, A., Stocker, M., Otero-Vaccarello, O., Szczapa, T., Sarafidis, K., Krolak-Olejnik, B., Memisoglu, A., Reigstad, H., Rafinska-Wazny, E., Hatzidaki, E., Peng, Z., Gkentzi, D., Viellevoye, R., De Buyst, J., Mastretta, E., Wang, P., Hahn, G., Bender, L., Cornette, L., Tkaczyk, J., del Rio, R., Fumagalli, M., Papathoma, E., Wilinska, M., Naulers, G., Sadowska-Kakrawczenko, I., Lecart, C., Couce, M. L., Fredly, S., Heuchan, A. M., Karen, T., Greisen, G.
10.1101/2020.10.02.20204578 — Posted: 2020-10-05
Testing mobile air purifiers in a school classroom: Reducing the airborne transmission risk for SARS-CoV-2
Curtius, J., Granzin, M., Schrod, J.
10.1101/2020.10.02.20205633 — Posted: 2020-10-05 Discussion: Onsite
An improved and readily available version of Bst DNA Polymerase for LAMP, and applications to COVID-19 diagnostics
Maranhao, A., Bhadra, S., Paik, I., Walker, D., Ellington, A. D.
10.1101/2020.10.02.20203356 — Posted: 2020-10-05 Discussion: Onsite
Combined metabolic cofactor supplementation accelerates recovery in mild-to-moderate COVID-19
ALTAY, O., YANG, H., AYDIN, M., Alkurt, G., ALTUNAL, N., KIM, W., AKYOL, D., ARIF, M., Zhang, C., Dinler-Doganay, G., TURKEZ, H., SHOAIE, S., NIELSEN, J., BOREN, J., DOGANAY, L., UHLEN, M., Mardinoglu, A.
10.1101/2020.10.02.20202614 — Posted: 2020-10-05 Discussion: Onsite
Antigen-based testing but not real-time PCR correlates with SARS-CoV-2 virus culture.
Pekosz, A., Cooper, C., Parvu, V., Li, M., Andrews, J., Manabe, Y. C. C., Kodsi, S., Leitch, J., Gary, D., Roger-Dalbert, C.
10.1101/2020.10.02.20205708 — Posted: 2020-10-05 Discussion: Offsite
Safety and efficacy of pharmacotherapy used for the management of COVID 19: A systematic review and meta-analysis of randomized control trials
Sah, S. K., Undela, K., Chand, D. S., Ramesh, M., R, S., Gona, O. J., George, S. M., UP, N., Aryal, S., P, N., Shastry, C. S.
10.1101/2020.10.02.20206045 — Posted: 2020-10-05
Impact of pathogen reduction technologies on immunological propertiesof the COVID-19 convalescent plasma
Kostin, A. I., Lundgren, M. N., Bulanov, A. Y., Ladygina, E. A., Chirkova, K., Gintsburg, A., Logunov, D., Dolzhikova, I., Shcheblyakov, D., Borovkova, N. V., Godkov, M. A., Bazhenov, A. I., Shustov, V., Bogdanova, A., Kamalova, A., Ganchin, V., Dombrovskiy, E., Volkov, S., Drozdova, N. E., Petrikov, S. S.
10.1101/2020.10.02.20205567 — Posted: 2020-10-05
Evaluating the Efficacy of COVID-19 Vaccines
Lin, D.-Y., Zeng, D., Mehrotra, D. V., Corey, L., Gilbert, P. B.
10.1101/2020.10.02.20205906 — Posted: 2020-10-05
Early transfusion of a large cohort of COVID-19 patients with high titer anti-SARS-CoV-2 spike protein IgG convalescent plasma confirms a signal of significantly decreased mortality
Salazar, E., Christensen, P. A., Graviss, E. A., Ngyuen, D. T., Castillo, B., Chen, J., Valdez Lopez, B., Eager, T., Yi, X., Zhao, P., Rogers, J., Shehabeldin, A., Joseph, D., Masud, F., Leveque, C., Olsen, R. J., Bernard, D. W., Gollihar, J., Musser, J. M.
10.1101/2020.10.02.20206029 — Posted: 2020-10-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).